What You Should Know:
GoodRx, a prescription savings platform, is stepping up to help with a new program offering 30 common heart health medications for under $30 at over 70,000 pharmacies nationwide.
Making Heart Health Affordable
- GoodRx recognizes the financial burden of managing heart disease and aims to improve access to affordable medications. By offering significant discounts on both generic and brand-name drugs, they target conditions like coronary artery disease, high
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Health Systems Grapple with AI Governance: Balancing Promise and Risk
What You Should Know:
- Despite the increasing adoption of artificial intelligence (AI) in healthcare, a new survey reveals that very few health systems have formal policies in place to govern its use, particularly for generative AI. In addition, 70% of executives plan to adopt AI solutions through EHR vendors for easier integration.
- The Center for Connected Medicine's full report, "How Health Systems are Navigating the Complexities of AI," offers a deeper dive into the survey findings
Read More
Insilico’s Potential Best-in-Class AI Drug for Sought-After Cancer Target
What You Should Know:
InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat advanced solid tumors characterized by TP53 mutation.The development is particularly significant for high-grade serous ovarian cancer (HGSOC), triple-negative breast cancer (TNBC), and non-small cell lung cancer
Read More
WellSpan Health Taps Biofourmis to Expand Hospital-at-Home Program
What You Should Know:
- WellSpan Health, a technologically advanced healthcare system, has partnered with Biofourmis to expand its award-winning hospital-at-home program.
- The strategic collaboration will leverage Biofourmis' remote patient management platform to streamline care delivery, improve patient outcomes, and reduce readmission rates.
Partnership Details
WellSpan currently manages one of the largest hospital-at-home programs in the U.S., caring for over 400 patients
Read More
VR Mask for PTSD Shows Promise in Decentralized Trial, Aims for FDA Breakthrough Designation
What You Should Know:
- Curavit Clinical Research, a leader in decentralized clinical trials (DCTs) for digital therapeutics (DTx), successfully completed a study for the Sana Device, a virtual reality (VR) mask aiming to reduce post-traumatic stress disorder (PTSD) symptoms.
- Overall, this study represents a significant step forward in the development of VR-based treatments for PTSD. If approved, the Sana Device could offer a valuable tool for patients struggling with this
Read More
Headlight Mental Health Scores $18M to Expand Teletherapy, In-Person Care
What You Should Know:
Headlight, a tech-forward mental health practice committed to offering patients convenience and a simplified care journey, today announced $18 million in new venture funding, led by Matrix and EPIC Ventures.Funding will help the company expand into additional states and add hundreds of new licensed therapists to their team by 2025. Prior to the transaction, Headlight added new executive leadership including Chief Executive Officer Geoff Swindle, former Chief
Read More
Xealth Digital Health Report Reveals 8 Emerging Trends for 2024
What You Should Know:
- Xealth, a leader in enabling digital health at scale, released its 2023 Digital Health Review, analyzing data from over 12 million digital health orders across nearly 30 health systems.
- The report highlights key trends and emerging areas for 2024, offering insights into the evolving digital health landscape.
Key Findings from 2023
Most Enrolled Patients: Surgery preparation and recovery programs saw the highest enrollment, reaching 1.5 million
Read More
How Open-Source Technologies Will Transform Digital Clinical Trials
Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel. Precedent exists for accelerating approval timelines during health emergencies such as the AIDs/HIV epidemic, where Compound S, a re-make of AZT, or azidothymidine, originally developed to fight cancer, became controversially fast-tracked after the discovery that it could block HIV activity. Likewise, when potentially lifesaving drugs are
Read More
AI Predicts Heart Attacks by Measuring Fat Around Your Heart, Study Finds
What You Should Know:
- New research from Cedars-Sinai uses artificial intelligence (AI) using a low-dose computed tomography (CT) scan to quickly and accurately measure heart fat, offering a promising tool for predicting and preventing heart disease.
- The technique, identified by the Division of Artificial Intelligence in Medicine and the Biomedical Imaging Research Institute at Cedars-Sinai, can help physicians better understand and manage heart disease risk in
Read More
DeepScribe Unveils Trust and Safety Suite, Setting AI Standards in Healthcare
What You Should Know:
- DeepScribe, a leader in AI-powered medical documentation solutions, has announced its Trust and Safety Suite, a new set of features designed to ensure the transparency, safety, and ethical use of AI in healthcare.
- Trust and Safety Suite aims to establish industry standards for responsible AI development and build trust in its technology among both healthcare professionals and patients.
Trust and Safety Suite Key Features
The Trust and Safety Suite three key
Read More
